Overall Burden of CVD Remained High in United Kingdom in 2000 to 2019

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, June 27, 2024 -- The overall burden of cardiovascular disease (CVD) remained high during 2000 to 2019 in the United Kingdom, according to a study published online June 26 in The BMJ.

Nathalie Conrad, Ph.D., from the University of Glasgow in the United Kingdom, and colleagues conducted a population-based study in the United Kingdom to examine the incidence of CVD overall and by age, sex, and socioeconomic status during 2000 to 2019. Data were included for 1,650,052 individuals registered with a general practice (mean age, 70.5 years; 47.6 percent women).

The researchers found that during 2000 to 2019, the age- and sex-standardized incidence of all 10 prespecified CVDs decreased by 19 percent (incidence rate ratio, 0.80 for 2017 to 2019 versus 2000 to 2002). Decreases of about 30 percent were seen for the incidence of coronary heart disease and stroke (incidence rate ratios, 0.70, 0.67, and 0.75 for acute coronary syndrome, chronic ischemic heart disease, and stroke, respectively). In parallel, diagnoses of cardiac arrhythmias, valve disease, and thromboembolic diseases increased. As a result, across the 10 conditions, the overall incidence of CVD remained relatively stable from the mid-2000s. The decline in incidence of coronary heart disease was mainly restricted to age groups older than 60 years; in younger age groups, there was little to no improvement. For almost all CVDs investigated, a socioeconomic gradient was observed.

"Our findings show that it is time to expand efforts to improve the prevention of CVDs," the authors write.

Several authors disclosed ties to the biopharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords